
NASDAQHealthcareMedical - Devices
最新数据
US$13.98
+US$0.54 · +4.02%
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
收盘时
US$13.98
+US$0.54 · +4.02%
盘后
US$13.98
US$0.00 · 0.00%
10月12日 16:10 ET
盘中时间采用ET。市场数据可能有所延迟。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日内区间
当前US$13.98
52周区间
当前US$13.98
盘中时间采用ET。市场数据可能有所延迟。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日内区间
当前US$13.98
52周区间
当前US$13.98
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 16.35亿 USD | 16.11亿 USD | 15.42亿 USD | 15.58亿 USD | 15.42亿 USD |
| 销货成本 | 7.9亿 USD | 7.28亿 USD | 6.57亿 USD | 5.87亿 USD | 5.98亿 USD |
| 毛利 | 8.45亿 USD | 8.82亿 USD | 8.85亿 USD | 9.7亿 USD | 9.45亿 USD |
| 研究与开发 | 9897.1万 USD | 1.15亿 USD | 1.04亿 USD | 1.01亿 USD | 9305.1万 USD |
| 销售、一般及管理费用 | 7亿 USD | 7.17亿 USD | 6.57亿 USD | 6.16亿 USD | 6.37亿 USD |
| 营业费用 | 7.77亿 USD | 8.54亿 USD | 7.73亿 USD | 7.31亿 USD | 7.47亿 USD |
| 利息收入 | 1847.4万 USD | 2004万 USD | 1720.2万 USD | 1191.7万 USD | 673.7万 USD |
| 利息支出 | 8625.5万 USD | 7063.2万 USD | 5137.7万 USD | 4959.4万 USD | 5039.5万 USD |
| 折旧和摊销 | 1.52亿 USD | 1.41亿 USD | 1.24亿 USD | 1.18亿 USD | 1.2亿 USD |
| 营业利润 | 6831.8万 USD | 2841.1万 USD | 1.12亿 USD | 2.39亿 USD | 1.97亿 USD |
| 净利润 | −5.16亿 USD | −694.4万 USD | 6774.1万 USD | 1.81亿 USD | 1.69亿 USD |
公司数据更新于 2026年10月12日。
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$19.40
上涨空间 38.77%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI3567.24万0.00%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard Morningstar Small-Cap ETFVB2571.18万0.01%1853亿 USD0.03%US$288.16-0.46%
iShares Russell 2000 ETFIWM2394.97万0.03%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR1634.93万0.02%682亿 USD0.05%US$234.71+0.12%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1444.35万0.05%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Extended Market ETFVXF1317.01万0.01%954亿 USD0.05%US$233.52-0.63%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM815.97万0.05%158.4亿 USD0.03%US$53.42-0.06%
Vanguard Russell 2000 ETFVTWO665.5万0.04%180亿 USD0.06%US$112.27-0.35%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Vanguard Russell 2000 ETFVTWOAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。